RecruitingPhase 2Phase 3NCT05459402

Divided or Single Exposure (DOSE) Study

Divided or Single Exposure (DOSE) Study: Randomized Controlled Trial for Pain in Persons Receiving Methadone Treatment

Sponsor

University of Maryland, Baltimore

Enrollment

150 participants

Start Date

Feb 21, 2023

Study Type

INTERVENTIONAL

Conditions

Chronic Pain Opioid-use Disorder Methadone

Summary

This study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Methadone (100% dose) and a drug called Methadone (50% dose) for people with chronic pain, methadone, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMethadone (100% dose)

Methadone for the treatment of opioid use disorder

DRUGMethadone (50% dose)

Methadone for the treatment of opioid use disorder

Locations(1)

Addiction Treatment Services (ATS)

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05459402

Related Trials

Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery

NCT076932701 location

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

NCT066511779 locations